Stocks Health care OPK
NASDAQ · Health careOpko Health, Inc. (OPK)
Opko Health, Inc. brought in $587.9M of revenue over the twelve months to June 30, 2026, down 11.5% from a year earlier. It posted a net loss of $72.9M. In fiscal 2025 capital spending exceeded operating cash flow by $190.8M. At June 30, 2026 it held $300.8M in cash against $349.1M of debt. Its latest periodic report to the SEC is the quarterly report (amended) (10-Q/A) filed on August 28, 2026.
What Opko Health, Inc. does
Opko Health, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OPK.
Revenue and profit by year
Key figures
| Fiscal year | Revenue | Net income | Diluted EPS | Free cash flow |
|---|---|---|---|---|
| 2025 | $606.9M | -$225.7M | -$0.30 | -$190.8M |
| 2024 | $713.1M | -$53.2M | -$0.08 | -$208.5M |
| 2023 | $863.5M | -$188.9M | -$0.25 | -$44.5M |
| 2022 | $1B | -$328.4M | -$0.46 | -$119.8M |
| 2021 | $1.8B | -$30.1M | -$0.05 | $6.2M |
| 2020 | $1.4B | $30.6M | $0.05 | $5.8M |
Latest SEC filings
What Opko Health, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.
- August 28, 2026Quarterly report (amended) 10-Q/A · period to June 30, 2026
- August 28, 2026Quarterly report (amended) 10-Q/A · period to March 31, 2026
- August 14, 2026
- August 7, 2026Activist stake (5% or more) SCHEDULE 13D
- July 27, 2026Quarterly report 10-Q · period to June 30, 2026
- July 27, 2026
- July 1, 2026Activist stake changed SCHEDULE 13D/A
- June 18, 2026
- May 15, 2026Additional proxy material DEFA14A
- April 30, 2026
Questions about OPK
What does Opko Health, Inc. do?
Opko Health, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker OPK.
Is Opko Health, Inc. profitable?
No. Over the twelve months to June 30, 2026 it reported a net loss of $72.9M on revenue of $587.9M.
How much revenue does Opko Health, Inc. make?
Over the twelve months to June 30, 2026 Opko Health, Inc. reported revenue of $587.9M. That is 11.5% less than a year earlier.
When did Opko Health, Inc. last report?
Its most recent periodic report is the quarterly report (amended) (10-Q/A) filed on August 28, 2026. It covers the period to June 30, 2026.
Similar companies
Follow OPK
Get an email when Opko Health, Inc. files with the SEC: results, executive changes, material agreements and annual reports.
Follow OPK: get an email when it filesWhere the numbers come from
Financial figures are the values Opko Health, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.
Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.